You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 15 No. 1, July 1966 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (34)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Metachromatic Leukodystrophy (MLD)

VII. Elevated Sulfated Acid Polysaccharide Levels in Urine and Postmortem Tissues

MARGARET BISCHEL, MD; JAMES AUSTIN, MD; MATTHIAS KEMENY

Arch Neurol. 1966;15(1):13-28.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

ACID polysaccharides (APS)* have become a focus of general biomedical interest since large excesses were reported in Hurler's syndrome (gargoylism).1,2,7 Large excesses of APS have also been noted in urine of two children who had a form of metachromatic leukodystrophy (MLD).3 Apart from their relationships with diseases, the APS in the normal nervous system have negative charge characteristics which may be of neurophysiological interest. For example, the net charge of APS molecules might influence the distribution of cations and positively charged molecules. In this manner APS might have some general bearing on the bioelectric potentials involved in neuronal excitation and transmission.

The purpose of the present study is three-fold: (1) to document and extend the APS observations in MLD; (2) to correlate them with the excess APS isolated from the brain and kidney of the same MLD children; and (3) to review a sizable expansion of the . . . [Full Text PDF of this Article]


Author Affiliations

PORTLAND, ORE

From the Division of Neurology, University of Oregon Medical School, Portland.


Footnotes

Submitted for publication Jan 24, 1966; accepted Feb 23.

In the present study ethanol fractionation techniques are used to obtain from one to three different APS fractions (Table 8). These fractions are designated APS I, APS II, and APS III. If keratosulfate or chondroitin sulfate B are present within these fractions, they are each identifiable chromatographically.15 With the chromatographic methods now available, the chondroitin sulfate A and C isomers are indistinguishable. Hence, a spot which could be either is categorized herein as "chondroitin sulfate A/C." Heparin and heparitin sulfate are not distinguishable chromatographically without prior hydrolysis. A spot which could be either is thus categorized as "heparin/heparitin sulfate." Less well-categorized APS moieties have also been encountered in the present study. On the basis of their chromatographic migration rates, these fall into two provisional groups: "unclassified group I" (of lower Rf) and "unclassified group II" (of higher Rf).15

Glycosaminoglycans is another name proposed for the acid polysaccharides (APS) considered here. This term emphasizes that these polysaccharides contain aminosugars. Other terminology for the APS studied here would be: keratosulfate=keratan sulfate; chondroitin sulfate A=chondroitin-4-sulfate; chondroitin sulfate B chondroitin sulfate C=chondroitin-6-sulfate; heparitin sulfate= heparan monosulfate.

Reprint requests to Division of Neurology, University of Oregon Medical School, Portland, Ore 97201 (Dr. Bischel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.